行情

ABBV

ABBV

艾伯维
NYSE

实时行情|Nasdaq Last Sale

88.63
+1.00
+1.14%
盘后: 88.41 -0.22 -0.25% 19:53 11/15 EST
开盘
88.10
昨收
87.63
最高
89.19
最低
87.26
成交量
804.14万
成交额
--
52周最高
94.98
52周最低
62.66
市值
1,310.68亿
市盈率(TTM)
39.68
分时
5日
1月
3月
1年
5年

分析师评级

11位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

ABBV 新闻

  • Investing returns are likely to be much lower in the years ahead, so here's what to do
  • CNBC.com.21小时前
  • FDA OKs Pfizer biosimilar to Humira
  • seekingalpha.1天前
  • Tracking Seth Klarman's Baupost Group Holdings - Q3 2019 Update
  • Seeking Alpha - Article.1天前
  • AbbVie Option Alert: Jan 17 $92.5 Calls at the Ask: 1900 @ $1.521 vs 3034 OI; Ref=$88.955
  • Benzinga.1天前

更多

所属板块

制药
+1.37%
制药与医学研究
+1.34%

热门股票

名称
价格
涨跌幅

ABBV 简况

AbbVie Inc. (AbbVie) is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture and sale of a range of pharmaceutical products. Its products are focused on treating conditions, such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease and multiple sclerosis; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis, and other serious health conditions. It offers products in various categories, including HUMIRA (adalimumab), Oncology products, Virology Products, Additional Virology products, Metabolics/Hormones products, Endocrinology products and other products, which include Duopa and Duodopa (carbidopa and levodopa), Anesthesia products and ZINBRYTA (daclizumab).
展开

Webull提供AbbVie Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。